17:01 IST
BSE
Bonus Issue
Fredun Pharmaceuticals Bonus Issue
Fredun Pharmaceuticals set July 16, 2026, as the record date for its 2:1 bonus issue. Shareholders will receive two new shares for every one held.
Fredun Pharmaceuticals Ltd
- Share price
- ₹1,476.05
- Market cap
- ₹2,109 Cr
- Revenue (annual)
- ₹635.5 Cr
- Net profit (annual)
- ₹32.62 Cr
- P/E (TTM)
- 48.1×Sector 47.3×
- Promoter holding
- 44.57%+0.40% QoQ
- FII holding
- 1.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Capital Structure Change 5Financial Results 4Earnings Call 3Results Update 2Other Announcement 2Bonus Issue 2Annual General Meeting 2Acquisition 2Product Launch 1Dividend 1Debt & Borrowing 1Capacity Expansion 1Business Update 1Board Meeting Outcome 1Board Meeting Date 1Annual Report 1
Time
2 announcements with these filters
17:54 IST
BSE
Bonus Issue
Fredun Pharmaceuticals Bonus Issue
Fredun Pharmaceuticals announced a 2:1 bonus issue following strong FY26 performance. The move reflects management's confidence in long-term growth and commitment to shareholder wealth.